Filings

TPST Tempest Therapeutics, Inc. 10-Q 2026-08-13

Item 1 · Note 1. Organization and Description of the Business

going concern for a period of 12 months from the date of issuance of these consolidated financial statements. The accompanying

9 matches in this document

TPST Tempest Therapeutics, Inc. 10-Q 2026-05-14

Item 1 · Note 1. Organization and Description of the Business

going concern for a period of 12 months from the date of issuance of these consolidated financial statements. The accompanying

9 matches in this document

TPST Tempest Therapeutics, Inc. 10-K 2026-03-30

Item 8 · Note 1. Organization and Description of Business

going concern for a period of 12 months from the date of issuance of these consolidated financial statements. The accompanying

11 matches in this document

TPST Tempest Therapeutics, Inc. 10-Q 2025-11-05

Item 1 · Note 1. Organization and Description of the Business

going concern for a period of 12 months from the date of issuance of these condensed financial statements. The accompanying

9 matches in this document

TPST Tempest Therapeutics, Inc. 10-Q 2025-08-11

Item 1 · Note 1. Organization and Description of the Business

going concern for a period of 12 months from the date of issuance of these condensed financial statements. The accompanying

8 matches in this document

TPST Tempest Therapeutics, Inc. 10-Q 2025-05-13

Item 1 · Note 1. Organization and Description of the Business

going concern for a period of 12 months from the date of issuance of these condensed financial statements. The accompanying

9 matches in this document

TPST Tempest Therapeutics, Inc. 8-K 2026-10-19

going concern; unexpected safety or efficacy data observed during preclinical or clinical trials; the possibility that results from prior clinical

1 match in this document

TPST Tempest Therapeutics, Inc. 8-K 2026-09-28

going concern; unexpected safety or efficacy data observed during preclinical or clinical trials; the possibility that results from prior clinical

1 match in this document

TPST Tempest Therapeutics, Inc. 8-K 2026-09-17

going concern; unexpected safety or efficacy data observed during preclinical or clinical trials; the possibility that results from prior clinical

1 match in this document

TPST Tempest Therapeutics, Inc. 8-K 2026-08-13

need for, and ability to obtain, additional capital to fund its planned programs and operations and continue as a going concern.

2 matches in this document

TPST Tempest Therapeutics, Inc. 8-K 2026-07-22

going concern; unexpected safety or efficacy data observed during preclinical or clinical trials; the possibility that results from prior clinical

1 match in this document

TPST Tempest Therapeutics, Inc. 8-K 2026-06-04

going concern; unexpected safety or efficacy data observed during preclinical or clinical trials; the possibility that results from prior clinical

1 match in this document

TPST Tempest Therapeutics, Inc. 8-K 2026-05-22

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

going concern; unexpected safety or efficacy data observed during preclinical or clinical trials; the possibility that results from prior clinical

1 match in this document

TPST Tempest Therapeutics, Inc. 8-K 2026-05-14

going concern; unexpected safety or efficacy data observed during preclinical or clinical trials; the possibility that results from prior clinical

1 match in this document

TPST Tempest Therapeutics, Inc. 8-K 2026-05-06

going concern; unexpected safety or efficacy data observed during preclinical or clinical trials; the possibility that results from prior clinical

1 match in this document

TPST Tempest Therapeutics, Inc. 8-K 2026-05-06

need for additional capital to fund its planned programs and operations and to continue to operate as a going concern;

1 match in this document

TPST Tempest Therapeutics, Inc. 8-K 2026-03-30

fund its planned programs and operations and to continue to operate as a going concern; unexpected safety or efficacy data observed

1 match in this document

TPST Tempest Therapeutics, Inc. 8-K 2026-02-25

going concern; unexpected safety or efficacy data observed during preclinical or clinical trials; the possibility that results from prior clinical

1 match in this document

TPST Tempest Therapeutics, Inc. 8-K 2025-11-26

going concern; and unexpected litigation or other disputes. These and other factors that may cause actual results to differ from

1 match in this document

TPST Tempest Therapeutics, Inc. 8-K 2025-11-05

going concern; availability of suitable third parties with which to conduct contemplated strategic transactions; whether we will be able to pursue

1 match in this document